missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Cytiva HiTrap™ MabSelect™ Prepacked Columns
Use these columns in small-scale MAb purification in a continuous bioprocess. Cytiva Life Sciences™ HiTrap™ MabSelect™ Prepacked Columns for fast purification of monoclonal antibodies (Mabs) from large sample volumes
Marca: Cytiva 28-4082-60
Detalles adicionales : CAS : 64-17-5 Peso : 0.09600kg
Descripción
Prepacked HiTrap columns for process development, screening of purification conditions, and small-scale purification of Mabs. MabSelect media are suited for the high flowrates and pressures required when scaling up.
- Oriented coupling of recombinant Protein A ligand to the agarose matrix via an engineered C-terminal cysteine increases IgG binding capacity over other protein A media
- High capacity, low ligand leakage, and high-flow base matrix allow purification of Mabs at process scale
- Fewer regulatory concerns due to the total absence of mammalian culture in the ligand production and purification
- Designed for use with a syringe, a peristaltic pump, or a chromatography system
MabSelect
- Allows at least five times higher flowrates than conventional cross-linked agarose of similar porosity
- Recombinant Protein A ligand promotes specificity of binding to Fc region of IgG; permits one-step purification
- Same recombinant protein A ligand as MabSelect, but with a smaller particle size and greater porosity, for increased dynamic binding capacity
- Allows binding from samples with high expression levels of the monoclonal antibody
- Lowers overall production cost due to the possibility of processing concentrated feedstocks in fewer batches
- Akali-tolerant protein A-derived ligand allows the use of up to 0.5M NaOH for cleaning-in-place (CIP)
- Permits significant cost savings and extension of cycles in regular production
Especificaciones
| ∼40 mg/mL Human lgG at 2.4 min. residence time | |
| 0.62 in. | |
| 5 mL | |
| 5 mL | |
| 4°C to 30°C |
| 1.6 cm | |
| <4 mL/min. | |
| For fast purification of monoclonal antibodies from large sample volumes, Protein Purification | |
| 20% Ethanol | |
| Each |